LBF20406LT05: Difference between revisions
No edit summary |
No edit summary |
||
Line 6: | Line 6: | ||
|LipidBank=XPR3114 | |LipidBank=XPR3114 | ||
|LipidMaps=LMFA03020012 | |LipidMaps=LMFA03020012 | ||
|SysName=N- (2- | |SysName=N- (2-Hydroxyethyl) - (5S,12R) -dihydroxy- (6-cis,8-trans,10-trans,14-cis) -icosatetraenamide | ||
|Common Name=&&Leukotriene B4 Ethanolamide&& | |Common Name=&&Leukotriene B4 Ethanolamide&&N- (2-Hydroxyethyl) - (5S,12R) -dihydroxy- (6Z,8E,10E,14Z) -eicosatetraenamide&& | ||
|Source= | |Source= | ||
|Chemical Synthesis= | |Chemical Synthesis= |
Revision as of 11:47, 1 June 2010
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR3114 |
LipidMaps | LMFA03020012 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20406LT05 |
Leukotriene B4 Ethanolamide | |
---|---|
Structural Information | |
N- (2-Hydroxyethyl) - (5S,12R) -dihydroxy- (6-cis,8-trans,10-trans,14-cis) -icosatetraenamide | |
| |
Formula | C22H37NO4 |
Exact Mass | 379.27225867699997 |
Average Mass | 379.53352 |
SMILES | C(=CC[C@@H](O)C=CC=CC=C[C@H](CCCC(=O)NCCO)O)CCCCC |
Physicochemical Information | |
LTB4-EA is reported as a potent antagonist about 3 fold higher affinity for the human LTB4 receptor that LTB4. And LTB4-EA antagonizes the LTB4-induced contractions of guinea pig lung parenchyma with 10 nM as an EC50. | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
|